Workflow
36氪
icon
Search documents
电商快递集体涨价,9块9包邮的时代要结束了?
36氪· 2025-11-27 10:02
Core Viewpoint - The recent price increase in the express delivery industry, although seemingly minor at 0.2-0.8 yuan per order, signifies a shift towards a new adjustment phase for the industry, impacting e-commerce operators and consumers significantly [6][10][20]. Price Increase Impact - The price hike began in July 2023 in Yiwu and has spread to 22 provinces, affecting e-commerce users while not impacting individual senders [6][5]. - The increase translates to an 8% loss in profit for low-margin products, particularly those priced at 9.9 yuan with free shipping [6][20]. - The average price per express delivery in the first half of 2025 was 7.52 yuan, down 7.7% from 8.15 yuan in 2024, indicating a trend of "increased revenue without increased profit" among major logistics companies [9][10]. Industry Dynamics - The express delivery sector has been characterized by a "price-for-volume" strategy, leading to unsustainable low pricing that has harmed both workers and service quality [10][12]. - The rise of "express delivery gray market" and "delivery scalpers" has emerged due to price discrepancies across regions, complicating the competitive landscape [14][15][16]. Reactions from Stakeholders - E-commerce operators are adjusting their pricing strategies, with some removing discounts to offset increased logistics costs, leading to a significant drop in order volumes [20][21]. - Consumers are experiencing changes in service quality, with many reporting that delivery personnel are less likely to deliver to their doors, opting instead for collection points [9][18]. - Despite the price increase, many delivery workers have not seen corresponding wage increases, raising concerns about the sustainability of their livelihoods [21][22]. Future Outlook - Analysts suggest that the industry needs to leverage technology such as AI and big data to optimize operations and improve service quality, while also exploring innovative delivery methods like unmanned delivery systems [21][22]. - The overarching goal of the price adjustments is to create a healthier industry environment that benefits both workers and consumers, fostering a more sustainable business model [22].
2025年度中国股权投资行业「产业并购」投资机构系列名册揭晓!
36氪· 2025-11-27 10:02
Core Insights - The year 2025 marks a significant turning point for China's M&A market, transitioning from "strategic attempts" to "systematic prosperity" due to supportive policies and macroeconomic resilience [2][3] - Capital is increasingly focused on high-quality assets with strong cash flow, brand equity, and market share, moving away from merely chasing high returns [3] - The pressure for exits in the primary market has led to innovative liquidity solutions, with M&A becoming a widely accepted exit strategy for investors and entrepreneurs [3] M&A Trends - Major M&A cases exceeding 5 billion have surpassed 25 by 2025, indicating a robust market environment [3] - Notable transactions include CPE Yuanfeng's acquisition of 83% of Burger King's China operations, which aims to enhance digital operations and local menu innovation [4] - The partnership between Boyu Capital and Starbucks exemplifies strategic collaboration, leveraging local insights to drive growth in lower-tier markets and digital transformation [4] Investment Institutions - The top investment institutions in China's industrial M&A for 2025 include: - Boyu Capital - Dinghui Investment - CPE Yuanfeng - Dazheng Capital - Dehong Capital - Sequoia China - Xincheng Capital - Hillhouse Capital - PAG - Kangqiao Capital [6] Notable M&A Cases - Significant M&A cases in 2025 include: - Dayao Soda - Gaoxin Retail - Burger King - Marshall - Boyu Capital - CPE Yuanfeng - KKR - Dehong Capital - WuXi AppTec - Julamat - Xingchujing - Dagan Capital - Hillhouse Capital - PAG [8]
今朝更好看|2025年度有限合伙人、国资、精品投行三大榜单揭晓
36氪· 2025-11-27 10:02
俱往矣。 出品 | 36氪创投研究院 2025年接近尾声,回望过去几年的中国一级市场,无疑经历了翻山越岭之艰辛与变化。 尤其在过去一年,一级市场出资结构完成阶段性调整。在整体节奏放缓之下,市场参与者机构与资金性质都已蜕变——国资体系机构、地方政府引导基金等 展现出其应有之稳定性与战略性,肩负产业升级与区域协同的「双重使命」,精准匹配国家战略,重点支持人工智能、先进制造、生命科学、新材料、新能 源等科技领域,并有效构建市场信心底盘。而带有其他属性的母基金、产业资本、保险资金等多元资本,也积极调整、发挥其差异化优势,参与产业变革之 中,进而推动创新创业的发展。 资产端退出也是市场聚焦的话题——我们关注到,并购事件相比以往频发:诸多PE机构开始寻求优质资产,为其注入金融资本角度的管理和加持。例如, CPE源峰收购汉堡王中国业务83%股权;博裕投资与星巴克达成战略合作,成立合资企业;红杉中国以11亿欧元的估值收购Marshall马歇尔的多数股权等 等。而一些专注在S基金交易的精品投行,也活跃于市场之间,以加速行业流动性。 基于以上市场变化和观察,我们首次设置了 「中国最具影响力国资投资机构」 ,并循例发布 「中国最受 ...
第一批倒下的智驾独角兽,给幸存者留下什么教训?
36氪· 2025-11-27 00:09
毫末智行只是第一批倒下的独角兽, 却不会是最后一个。 今年11月下旬,中国首个实现自动驾驶技术量产的公司——毫末智行突然宣布全员停工。 这家成立六年,估值曾炒到10亿美元的智能驾驶独角兽,最终没能挺过这个冬天。在不少人看来,毫末智行倒在了技术掉队、订单被抢的行业攻防战之 中。但如果只把毫末智行的"停摆"理解为某家公司的失败,反而忽略了智能驾驶行业真正的结构性问题——支撑中国智驾过去五年高歌猛进的几乎所有前 提,都在同一时间"失效"。 毫末智行只是第一批倒下的独角兽,却不会是最后一个。 智能驾驶: 从"试错期"进入"清算期" 面对毫末智行的"停摆",外界的第一反应大多是"怎么会来得这么突然?"但在行业内部,真正了解自动驾驶商业逻辑的人反而不会那么意外。要理解毫末 智行迎来"停摆"的必然性,需要从行业本身的周期变化说起。过去五年,中国智能驾驶跑在一个"真空"环境里。资本愿意补贴未来,车企愿意押注技术, 用户愿意尝鲜技术。 这三大基础像是三根支撑整个赛道的梁木,虽然独木难支却互相牵引、制衡,让整个行业维持着高速发展。然而到了2024年,这三根梁木同时"断裂"。 当标配成为主流,行业也对订阅商业模式的前景彻底"祛魅" ...
8点1氪:香港火灾已致44人遇难;罗永浩喊话华杉公开道歉,无人应声;飞机锁座变相收费,10家航空公司被约谈
36氪· 2025-11-27 00:09
Group 1 - The Hong Kong fire incident in Tai Po has resulted in 44 fatalities and 45 injuries, with three individuals arrested for suspected manslaughter due to negligence in fire safety standards [2] - The fire spread rapidly, potentially exacerbated by flammable materials used in the building's exterior, leading to a police investigation into the responsible engineering company [2] Group 2 - Sinovac Biotech has secured a $700 million contract in Brazil, marking the largest international order for a Chinese vaccine company to date [5] - The contract involves a partnership with local firms to enhance Brazil's vaccine production capabilities over the next decade [5] Group 3 - HP has announced a global layoff of approximately 10% of its workforce as part of a comprehensive AI transformation plan aimed at cost reduction [8] - The company plans to cut 4,000 to 6,000 jobs by the end of the 2028 fiscal year, targeting annual savings of $1 billion through AI integration [8] Group 4 - Ideal Auto reported a revenue of 27.4 billion yuan for Q3 2025, a year-on-year decline of 36.2%, with a net loss of 624 million yuan [22] - The company anticipates vehicle deliveries between 100,000 and 110,000 units in Q4 2025 [22] Group 5 - HighTu announced a revenue of 1.579 billion yuan for Q3 2025, reflecting a year-on-year growth of 30.7%, while reporting a net loss of 147.1 million yuan [23] - The company continues to show resilience in its financial performance despite the losses [23] Group 6 - ByteDance's "Tomato" business is projected to exceed 60 billion yuan in overall revenue this year, with significant contributions from its various platforms [9] - The company has denied reports regarding the accuracy of these revenue figures [9] Group 7 - OpenAI forecasts that by 2030, it will have 220 million paid subscribers for ChatGPT, representing 8.5% of its estimated 2.6 billion weekly users [21] - The company anticipates annual revenue of approximately $20 billion by the end of this year, despite increasing losses [21]
提供CGT产品安全性评价服务,「唯可生物」获近亿元A轮融资|早起看早期
36氪· 2025-11-27 00:09
文 | 胡香赟 编辑 | 海若镜 累 计已服务 70多家药企及科研机构类客户,涉及国内外管线超过100个。 封面来源 | 企业官网 36氪获悉,唯可生物近期已完成近亿元A轮融资。本轮融资由深创投领投,锡创投跟投,募集资金主要用于加速推进细胞和基因 治疗(CGT)美国安评检测中心搭建、CGT安评服务、CGT临床服务和生物育种服务的海外业务拓展等工作。丰和资本任独家财 务顾问。 唯可生物专注于为细胞与基因治疗(CGT)药物提供基于安全性评价的CRO服务,核心团队均来自于德国海德堡大学和德国国家 癌症研究中心,在CGT安评领域拥有多年从业经历,曾协助诺华的CAR-T药物Kymriah、BioMarin的血友病药物Roctavian等多款 基因治疗产品获批上市。 "2021年左右,随着国内CGT领域逐步发展、CAR-T疗法等代表性产品相继上市,监管部门对这类产品的安全性检测工作也愈发 重视。在此背景下,我们与德国GENEWERK团队合作将相关检测技术引进、升级,创办了唯可生物。"唯可生物创始人吴宁表 示。 据了解,现阶段,唯可生物可以为CGT药物提供从药物早期临床研发,CMC开发,到后期IIT临床和注册临床试验、长时 ...
爆丑闻全球退款1.4亿?被称复购率最高「英国奢侈品」害惨多少中国留子
36氪· 2025-11-27 00:09
Core Viewpoint - The IELTS examination has faced a significant technical failure that has led to systematic misjudgment of scores, affecting around 70,000 candidates and resulting in a refund of approximately 140 million yuan. This incident highlights the severe implications of such errors on students' academic and career trajectories [6][7][21]. Group 1: Impact of the Technical Failure - The technical failure has caused score changes ranging from 0.5 to 1.5 points, which, in the context of a maximum score of 9, can drastically alter a candidate's eligibility for university admissions [6][12]. - Many students, like Wang Cheng, found themselves needing to retake language classes or reprepare for the IELTS due to the unexpected drop in their scores, leading to additional financial burdens and time loss [14][15]. - The emotional toll on students has been significant, with some experiencing feelings of failure and self-doubt due to the reliance on a flawed system [19][21]. Group 2: Financial Aspects and Market Position - The IELTS exam fee has increased significantly over the past decade, rising from 1550 yuan to 2170 yuan, a nearly 50% increase, which places a financial strain on candidates [25]. - Despite the increase in fees, the average price for the IELTS in China remains higher than in other countries, such as Japan, where it costs between 1200 to 1400 yuan [25][28]. - The British Council, one of the main operators of the IELTS, is facing a financial crisis, with reports of consecutive losses and a warning of potential bankruptcy if government intervention does not occur [35][36]. Group 3: Competitive Landscape and Future Outlook - The IELTS is facing competition from alternative English proficiency tests, such as Duolingo, which offer more accessible and affordable options for students [37]. - In response to the declining demand for English tests, IELTS has announced a price reduction for the first time in 36 years, lowering the fee to 1990 yuan starting January 2026 [39]. - The overall decline in demand for English proficiency tests has prompted IELTS and its partners to explore new revenue streams, including student placement services [36].
对话萧家乐:从「在中国、为中国」再到「爱中国」,阿迪达斯的下一个Big Thing
36氪· 2025-11-26 13:39
Core Viewpoint - Adidas aims to recover from its low point in three years, with recent quarterly performance showing a 10% year-on-year revenue increase to €947 million in Greater China, attributed to the "In China, For China" strategy [1][3]. Group 1: Localization Strategy - The localization strategy has led to nearly 95% of products sold in China being locally produced, with 60% designed in China, surpassing the global CEO's targets [1]. - The shift from "For China" to "Love China" signifies Adidas's deeper commitment to the Chinese market, emphasizing emotional connections with consumers [3]. - True localization involves integrating the brand into the daily narratives of consumers, aiming for 100% emotional resonance rather than just numerical metrics [7][10]. Group 2: Product Development and Consumer Engagement - The Shanghai Creative Center (CCS) has been pivotal in creating culturally relevant products, with over 80% of showcased items set to be commercialized [8][10]. - Adidas focuses on continuous product iteration based on consumer feedback, enhancing its connection with local users [8][10]. - The brand is shifting its marketing approach to emphasize lifestyle and enjoyment in sports, particularly targeting the growing female consumer segment through initiatives like street dance [12][14]. Group 3: Market Expansion and Future Outlook - Adidas is expanding into third- and fourth-tier cities and the children's market, with plans to open 700 new stores in collaboration with local partners [22]. - The establishment of the Adidas University Sports Community reflects a long-term commitment to youth sports in China, providing comprehensive support to university teams [19][21]. - The company maintains a strong focus on sustainability, aiming to lead in environmental indices despite broader industry cost-cutting trends [22].
白酒经销商,一年亏3000万
36氪· 2025-11-26 13:39
Core Viewpoint - The white liquor industry is facing significant challenges, with many distributors reporting severe financial losses and a saturated market leading to price inversions and cash flow pressures [7][8][10]. Group 1: Market Conditions - In Q3 2025, 18 out of 20 listed liquor companies reported declining profits, with some experiencing net profit drops exceeding 90% [7]. - Over 50% of white liquor distributors reported worsening price inversions, and more than 40% faced cash flow issues [8]. - The market is described as overly saturated, with distributors unable to sell inventory at profitable prices, leading to significant financial strain [10][15]. Group 2: Distributor Challenges - Distributors are experiencing a "reverse snowball" effect, where the value of inventory decreases with each new payment made to manufacturers [29][30]. - Many distributors are reducing their operational scale, cutting costs, and downsizing staff in response to the financial pressures [17][24]. - The relationship between distributors and manufacturers is becoming strained, with some distributors opting to limit their purchases to avoid losing their distribution rights [10][19]. Group 3: Consumer Behavior and Future Outlook - There is a perception that younger consumers are not engaging with white liquor, although some distributors believe this is temporary and linked to age rather than a permanent shift in consumption habits [10][32]. - The industry is undergoing a transformation influenced by new technologies and changing social values, which may impact traditional consumption patterns [10][11]. - Distributors are contemplating a shift towards online sales, although there are concerns about the associated costs and competition from low-priced online offerings [17][18].
流感「抬头」,疫苗价「雪崩」,行业协会坐不住了
36氪· 2025-11-26 13:39
Core Viewpoint - The article discusses the ongoing price war in China's vaccine industry, driven by changes in supply and demand dynamics, leading to significant price reductions and financial losses for companies [4][15][22]. Group 1: Price War Dynamics - The price of a three-valent flu vaccine has dropped to 5.5 yuan, cheaper than a cup of milk tea, indicating a severe price competition in the vaccine market [5][11]. - The China Vaccine Industry Association has issued an initiative to combat "involution-style" competition, urging members to avoid bidding below cost and threatening penalties for violations [6][8][10]. - The price war has persisted for two years, with the association's initiative being the first formal stance against low-price competition, although it may not resolve the underlying issue of overcapacity [6][10][22]. Group 2: Supply and Demand Changes - The supply side is characterized by homogenization and overcapacity, with many companies entering the vaccine market, leading to intense competition and price wars [16][17]. - Demand is also under pressure, with declining public trust in vaccines and a decrease in vaccination rates, particularly for flu vaccines, which averaged below 4% in China from 2020 to 2023 [17][19]. - The shift in focus from childhood vaccines to adult vaccines due to declining birth rates has intensified competition in the adult vaccine market [17][19]. Group 3: Financial Impact on Companies - The financial repercussions of the price war are evident, with vaccine companies experiencing a 60% drop in revenue and a 113% decline in net profit in the first half of 2025 [19][20]. - Major companies like Zhifei Biological and Wantai Biological have reported significant losses, with Zhifei's revenue down 66.53% and net profit loss of 12.06 billion yuan [20][21]. - Despite some companies showing growth in sales, the overall trend indicates that increased revenue does not equate to increased profit due to drastic price reductions [21][22]. Group 4: Future Outlook and Strategies - Experts suggest that the industry is in a "deep cold moment," requiring a period of consolidation and restructuring that could last five to ten years [23]. - Companies are exploring two main strategies to navigate the competitive landscape: expanding into emerging markets and focusing on differentiated products to meet unmet clinical needs [24].